Home > Will the ADAPT Study Revolutionize Treatment Approaches in Colorectal Cancer?
Colorectal Cancer

Will the ADAPT Study Revolutionize Treatment Approaches in Colorectal Cancer?

Published Online: April 23rd 2015

Dr. Edward Lin discusses why a combination of what some might call an unlikely pair of drugs that with precise timing can prove effective in waking up sleeping cancer stem cells—giving treatment a better shot at fighting colorectal cancer. Dr. Edward Lin, a medical oncologist at SCCA, an associate professor at the University of Washington, and an associate member of the Fred Hutchinson Cancer Research Center is leading the ADAPT trial and explains what he is hopeful for and how this may change the way we look at the disease.

Share this Video
Related Videos In Colorectal Cancer
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar